Key result
TAPSEnorm predicted fluid responsiveness in hospitalised dogs with an AUROC of 0.827 (95% CI 0.65-1.00), with lower values observed in fluid-responsive dogs (0.57 vs 0.76 cm/kg).
Why the study?
To evaluate normalized tricuspid annular plane systolic excursion as a predictor of fluid responsiveness and investigate its association with normalized left ventricular internal diameter in diastole and aortic velocity time integral in hospitalized dogs.
Does TAPSEnorm predict fluid responsiveness in hospitalised dogs with haemodynamic and tissue perfusion alterations?
Observational
No
Does TAPSEnorm predict fluid responsiveness in hospitalised dogs with haemodynamic and tissue perfusion alterations?
Effect estimate: AUROC 0.827 (95% CI 0.65-1.00)
Absolute Event Rate: 0.57% vs 0.76%
TAPSEnorm is a valuable echocardiographic tool for evaluating blood volume status and predicting fluid responsiveness in hospitalised dogs with circulatory abnormalities.
May support TAPSEnorm for predicting fluid responsiveness in dogs; leaves open clinical adoption pending prospective validation.
Aims To evaluate the echocardiographic variable tricuspid annular plane systolic excursion normalised to body weight (TAPSEnorm) as a predictor of fluid responsiveness in hospitalised dogs with haemodynamic and tissue perfusion alterations and to investigate the association of left ventricular internal diameter in diastole normalised to body weight (LVIDdN) and aortic velocity time integral (VTIAo) with TAPSEnorm.Methods A single-centre, prospective study was carried out in a cohort of spontaneously breathing dogs, hospitalised for any reason, with severe haemodynamic and tissue perfusion alterations. The echocardiographic variables TAPSEnorm, LVIDdN, and VTIAO were measured. A bolus of 30 mL/kg of lactated Ringer’s solution was administered and then VTIAo was subsequently remeasured. Patients were classified as fluid responsive if VTIAo increased by ≥15% after fluid expansion, or non-responsive if VTIAo increased by <15% after fluid expansion. The area under the receiver operating characteristic (AUROC) curve was generated to evaluate the ability of TAPSE to predict fluid responsiveness. Simple regression models were used to assess the linear relationship between TAPSEnorm and LVIDdN or VTIAO.Results TAPSEnorm was lower in fluid responsive dogs (mean 0.57 (95% CI = 0.50–0.64) cm/kg) compared to non-responsive dogs (mean 0.76 (95% CI = 0.62–0.90) cm/kg). The AUROC for TAPSEnorm was 0.827 (95% CI = 0.65–1.00). The optimal cut-off point was 0.76 with sensitivity of 80 (95% CI = 28.4–99.5)% and specificity of 86.7 (95% CI = 69.3–99.2)%, positive predictive value of 50 (95% CI = 15.7–84.3)% and negative predictive value of 96.3 (95% CI = 81–99.9)%. A monotonic linear relationship was observed between TAPSEnorm and LVIDdN (p<0.001) and between TAPSEnorm and VTIAo (p=0.001).Conclusions and clinical relevance TAPSEnorm could be useful in determining those dogs that are likely to respond to a fluid bolus from those that are likely to be non-responsive. Additionally, a positive linear association between the LVIDdN and the TAPSEnorm suggests that TAPSEnorm decreases at lower preload values. The present study results suggest that TAPSEnorm could be a valuable tool for evaluating blood volume status and fluid responsiveness in hospitalised dogs.
No takes yet. Share an insight, caveat, or question.
Donati et al. (2022) conducted an observational in Haemodynamic and tissue perfusion alterations. TAPSEnorm (tricuspid annular plane systolic excursion normalised to body weight) was evaluated on Fluid responsiveness (VTIAo increased by ≥15% after fluid expansion) (AUROC 0.827, 95% CI 0.65-1.00). TAPSEnorm predicted fluid responsiveness in hospitalised dogs with an AUROC of 0.827 (95% CI 0.65-1.00), with lower values observed in fluid-responsive dogs (0.57 vs 0.76 cm/kg).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: